We’re Redefining Regenerative Medicine
science of xenotransplantation towards
with partners, investigators and academic institutions to develop new biotherapies.
Lead xenotransplantation to become the
for regenerative medicine.
XenoTherapeutics Foundation is a not-for-profit, clinical-stage regenerative medicine company developing new biotherapies from genetically engineered animals.
We understand the critical healthcare needs of a growing global population, and that is why we are dedicated to accelerating the testing, development, training, and commercialization of innovative, live biotherapeutic products to ensure that there will always be a sufficient supply to meet the true demand of the population.
In our research collaboration with Alexis Bio, we have developed our first product, realSKIN , which is pioneering the field of clinical xenotransplantation (transplantation of cells, tissues, and organs from one species to another).
Today the Xeno team has accomplished preclinical development in two IND-enabling studies for new biotherapies (skin and peripheral nerve transplants), progressed to Phase 3 clinical trials in a new field of medicine, and attained Orphan Drug and Regenerative Medicine Advanced Therapy Designations from the FDA for realSKIN .